Charles DeCarli, MD


  • 44642 Citations
  • 104 h-Index
1981 …2021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Charles DeCarli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles
Alzheimer Disease Medicine & Life Sciences
Brain Medicine & Life Sciences
Dementia Medicine & Life Sciences
Cognition Medicine & Life Sciences
Cerebrovascular Disorders Medicine & Life Sciences
Magnetic Resonance Imaging Medicine & Life Sciences
Atrophy Medicine & Life Sciences
Stroke Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1981 2021

Translational Medical Research


DeCarli, C., Mathis, C., Biegon, A., Eberling, J. L., Jagust, W. J., Lindeman, D., Weiler, P., Hinton, W. L., Mungas, D. M., Beckett, L. A., Carter, C. S., Haan, M. N., Ellis, W., Olichney, J. M. & Jin, L.

National Institutes of Health


Project: Research project

Alzheimer Disease
Antibody-Dependent Cell Cytotoxicity
Organized Financing
Life Style

Research Output 1986 2019

3 Citations (Scopus)

A blood-based signature of cerebrospinal fluid Aβ 1–42 status

Alzheimer’s Disease Metabolomics Consortium & Alzheimer’s Disease Neuroimaging Initiative, Dec 1 2019, In : Scientific Reports. 9, 1, 4163.

Research output: Contribution to journalArticle

Open Access
Cerebrospinal Fluid
Alzheimer Disease
Positron-Emission Tomography
Area Under Curve
1 Citation (Scopus)

A comparison of automated segmentation and manual tracing in estimating hippocampal volume in ischemic stroke and healthy control participants

Khlif, M. S., Egorova, N., Werden, E., Redolfi, A., Bocardi, M., DeCarli, C., Fletcher, E., Singh, B., Li, Q., Bird, L. & Brodtmann, A., Jan 1 2019, (Accepted/In press) In : NeuroImage: Clinical. 101581.

Research output: Contribution to journalArticle

Healthy Volunteers
Stroke Volume
3 Citations (Scopus)

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

DESGESCO (Dementia Genetics Spanish Consortium), EADB (Alzheimer Disease European DNA biobank), EADB (Alzheimer Disease European DNA biobank), IFGC (International FTD-Genomics Consortium), IPDGC (The International Parkinson Disease Genomics Consortium), IPDGC (The International Parkinson Disease Genomics Consortium), RiMod-FTD (Risk and Modifying factors in Fronto-Temporal Dementia), Netherlands Brain Bank (NBB) & The GIFT (Genetic Investigation in Frontotemporal Dementia and Alzheimer’s Disease) Study Group, Jan 1 2019, In : Acta Neuropathologica.

Research output: Contribution to journalArticle

Open Access
Lewy Body Disease
Frontotemporal Dementia
Alzheimer Disease
Neurodegenerative Diseases

Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients

Jang, H., Kim, H. J., Park, S., Park, Y. H., Choe, Y., Cho, H., Lyoo, C. H., Yoon, U., Lee, J. S., Kim, Y., Kim, S. J., Kim, J. P., Jung, Y. H., Ryu, Y. H., Choi, J. Y., Moon, S. H., Seong, J. K., DeCarli, C., Weiner, M. W., Lockhart, S. N. & 3 others, Cho, S. H., Na, D. L. & Seo, S. W., Jan 1 2019, (Accepted/In press) In : European Journal of Nuclear Medicine and Molecular Imaging.

Research output: Contribution to journalArticle

Blood Vessels
Alzheimer Disease
Cognitive Dysfunction
Cerebral Small Vessel Diseases
4 Citations (Scopus)

Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes

Pase, M. P., Beiser, A. S., Himali, J. J., Satizabal, C. L., Aparicio, H. J., DeCarli, C., Chêne, G., Dufouil, C. & Seshadri, S., Jan 1 2019, In : JAMA neurology.

Research output: Contribution to journalArticle

Cerebrospinal Fluid
Odds Ratio